SOLV Solventum Corporation
XNYS
86.67
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
SOLV
$86.67
—
Key stats
$86.67
- 52-Week Range
- $62.38 – $94.16
- YTD
- +9.68%
- IV Rank (30D)
- 95.35
- Straddle Price
- $7.88
- P/C Vol Ratio
- 0.02
- Market Cap
- $14.7B
- Open
- $85.74
- Day Range
- $85.35 – $86.88
- Volume
- 812,799
- Prev Close
- $86.39
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.09% |
| Beta vs SPY | 0.73 |
| Cost of Equity (CAPM) | 8.74% (VRP-adj) |
| WACC | 8.06% |
| Volatility Risk Premium | +44.8pp (IV − HV30) |
| Effective Tax Rate | 15.4% |
| Rev. Growth (YoY, DCF input) | +5.4% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.05 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.1B |
| Return on Equity (TTM) | 29.9% |
| Book / Price | 31.8% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 54.7% |
| FCF Margin (TTM) | -1.4% |
| Debt / Equity | 1.00 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $88.50 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $87.39 |
| Bollinger Width / SMA20 | 6.9% (drives anchor stability) |
| Net Debt | $4.4B |
| Market Cap | $15B |
Peers used for multiples: CI, GEHC, HUM, UNH, VTRS
(filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
31%
20-Day Fair Value
≈ by Nov 19, 2026
$87.55
α +1.0%
rank 26%
conviction
60%
40-Day Fair Value
≈ by Dec 18, 2026
$88.60
α +2.2%
rank 25%
conviction
68%
60-Day Fair Value
≈ by Jan 18, 2027
$87.40
α +0.8%
rank 26%
conviction
31%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $179.66 | 11% | median 20.9× · 4 peers |
| Peer EV/EBITDA | $46.88 | 11% | median 11.6× · 5 peers |
| Peer P/B | $71.09 | 2% | median 2.6× · 5 peers |
| Peer P/S | $40.57 | 7% | median 0.8× · 5 peers |
| Market Anchor (SMA50) | $88.50 | 48% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $86.19 | 21% | 18 strikes · skew +0.23 |
As of 2026-10-21 · updated
Related
About
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
- Exchange
- XNYS
- Market Cap
- $14.7B
- Employees
- 20,000
- List Date
- 2024-03-26
- CIK
- 0001964738
- Next Earnings
- 2026-11-05 (After-Close)
- EPS Forecast
- $1.35 (5 est.)
- Headquarters
- Eagan, MN
- Homepage
- https://www.solventum.com
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '24 | '25 | '26 | Avg |
|---|---|---|---|---|
| Jan | -- | 12.33% | -2.59% | 4.87% |
| Feb | -- | 8.39% | -3.52% | 2.44% |
| Mar | -- | -5.14% | -10.55% | -7.85% |
| Apr | -5.92% | -13.39% | 4.68% | -4.88% |
| May | -8.92% | 11.38% | 12.49% | 4.98% |
| Jun | -7.31% | 3.72% | 1.73% | -0.62% |
| Jul | 14.44% | -8.38% | 8.59% | 4.88% |
| Aug | 10.42% | 1.90% | 3.40% | 5.24% |
| Sep | 9.23% | 1.64% | -3.08% | 2.60% |
| Oct | 7.85% | -5.48% | -1.25%* | 0.37% |
| Nov | -1.31% | 25.16% | -- | 11.93% |
| Dec | -8.24% | -7.39% | -- | -7.81% |
| Total | 7.07% | 20.14% | 8.22% | 11.81% |
* Only 3 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $87.30
SMA 50: $88.55
SMA 200: $78.35
Current: $86.67
EMA 12: $86.68
EMA 26: $87.27
MACD: -0.5941 | Signal: -0.0829
BEARISH
ADX (14): 16.72
RANGE
+DI: 19.32
−DI: 25.72
Momentum Oscillators
RSI (14): 47.29
NEUTRAL
Stoch %K: 44.59
Stoch %D: 42.98
Williams %R: -45.13
Volume & Volatility
BB Upper: $89.91
BB Lower: $84.69
NEUTRAL
OBV: -1,873,567
Vol SMA 20: 942,246
Vol ROC: -17.16%
ATR: $2.05
True Range: $1.53
HV 20: 18.1%
HV 30: 19.8%
HV 60: 23.7%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-23T00:00:00 – 2026-10-21T00:00:00
AI Analysis
LLM Stock Analysis Report - SOLV
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 7)
Key Drivers and Primary Risks:
- Strong technical signals, with a bullish MACD crossover and RSI in neutral territory
- Positive news sentiment, driven by recent earnings reports and industry trends
- Low volatility, indicating a stable market environment
Investment Thesis: SOLV presents a mixed bag of technical and fundamental factors. While the stock has shown resilience in recent months, its growth potential is hampered by relatively low volatility and a lackluster options market.
Recent News Sentiment Impact:
- Positive news headlines have contributed to the stock's upward momentum, particularly the strong earnings report from Q3 2025
- Neutral sentiment from general market commentary has not significantly impacted the stock
Technical Analysis
Trend Direction: Medium-term (1-3 months) uptrend
Support/Resistance Levels:
- SMA 20: $79.77 (support)
- EMA 12: $82.48 (resistance)
Momentum Signals:
- RSI: 62.48 (neutral)
- MACD signal: Bullish crossover
- Bollinger Bands position: Squeeze
Volume Analysis: Low volume, with a decline in recent weeks
News & Sentiment Analysis
Recent Headlines Summary:
- Positive news headlines have focused on the company's strong earnings and industry trends
- Neutral market commentary has not had a significant impact on the stock
Sentiment Assessment: POSITIVE (80% positive sentiment)
Catalyst Identification:
- No major upcoming events or announcements that could significantly impact the stock
Market Narrative: The news narrative is generally supportive of the stock, with recent earnings reports and industry trends driving positivity
Risk & Volatility Assessment
Beta Interpretation: Low risk relative to market (beta = 0.64)
Volatility Regime: Low volatility regime
Options Market Signals:
- IV rank: Medium
- Put/call ratios: Bullish sentiment
- Unusual activity: Limited trading volume and open interest in options contracts
Downside Protection: Support levels from moving averages and technical patterns
Market Context & Positioning
Sector Performance: SOLV has outperformed the overall market, with a relatively strong performance in its sector
Institutional Activity: Low institutional participation, indicating limited trading volume and open interest
Correlation Analysis: SOLV has exhibited low correlation with the broader market (R-squared = 0.28)
Relative Valuation: Position within trading range, with no clear overbought or oversold conditions
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $79.77 (support)
- EMA 12: $82.48 (resistance)
Breakout/Breakdown Levels:
- Bollinger Bands upper band: $87.54 (breakout potential)
- Lower band: $71.99 (breakdown risk)
Time-Sensitive Catalysts: No major upcoming events or announcements that could significantly impact the stock
Risk Management: Stop-loss levels and position sizing considerations based on market volatility and technical signals
Generated
News
All SOLV news →
Earnings History
9 of 10 under expected move
Avg Expected Move
7.89%
Avg Actual Move
3.98%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-05-09 | After-Close | 4.47% | 1.68% | 0.38x | Within |
| 2024-08-08 | After-Close | 8.31% | 3.29% | 0.40x | Within |
| 2024-11-07 | After-Close | 9.06% | 3.52% | 0.39x | Within |
| 2025-02-27 | After-Close | 9.29% | 4.42% | 0.48x | Within |
| 2025-05-08 | After-Close | 9.57% | 5.40% | 0.56x | Within |
| 2025-08-07 | After-Close | 7.19% | 2.00% | 0.28x | Within |
| 2025-11-06 | After-Close | 7.62% | 7.91% | 1.04x | Exceeded |
| 2026-02-26 | After-Close | 8.97% | 3.56% | 0.40x | Within |
| 2026-05-05 | After-Close | 6.88% | 2.82% | 0.41x | Within |
| 2026-08-05 | After-Close | 7.52% | 5.16% | 0.69x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
SOLV Options Activity & IV Rank
SOLV IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 39.4%
7-DTE IV: —
Expected Move: $7.88
7-DTE Move: $7.88
Days to Exp: 30 (2026-11-20)
Options Flow
Call Volume: 1,656
Put Volume: 30
P/C Volume: 0.018
BULLISH
Call OI: 3,809
Put OI: 1,280
P/C OI: 0.336
Total OI: 5,089
ATM Options Pricing
ATM Call: $4.60
ATM Put: $3.27
Call %: 5.3%
Put %: 3.8%
Chain Summary
Chain Volume: 1,874
Chain OI: 9,157
Last Updated: 10/21/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 40th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
40%
vs own history
GEX tilt
+0.25
OI-weighted, today
Vanna tilt
+0.66
δ-sensitivity to IV
Charm tilt
-0.74
δ-decay vs time
Vanna tilt +0.66: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.74: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 20 ATM contracts, 4k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Oct 21 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Oct 21 · ATM 38.9% / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)95.3HighOct 21
Straddle Price (30 DTE)$7.88Oct 21
Beta Analysis
Risk Metrics
Beta: 0.5653
Alpha: 13.28%
Correlation: 0.2415
R-Squared: 5.8%
Stock Volatility: 29.7%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
SOLV Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 174,875,000 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
9 filers$33.37M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Twin Tree Management, LP | $10.82M | 32.42% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $7.22M | 21.64% | 2026-06-30 |
| 3 | Susquehanna International Group, LLP Custodian | $3.95M | 11.84% | 2026-06-30 |
| 4 | PEAK6 LLC | $3.86M | 11.56% | 2026-06-30 |
| 5 | Jane Street Group, LLC Custodian | $3.80M | 11.40% | 2026-06-30 |
| 6 | Wolverine Trading, LLC Custodian | $1.70M | 5.11% | 2025-09-30 |
| 7 | Walleye Capital LLC | $1.33M | 3.98% | 2026-06-30 |
| 8 | BlueCrest Capital Management Ltd | $462.90K | 1.39% | 2026-06-30 |
| 9 | TUDOR INVESTMENT CORP ET AL | $223.74K | 0.67% | 2026-06-30 |
6 filers$11.88M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $5.98M | 50.31% | 2026-06-30 |
| 2 | Twin Tree Management, LP | $4.05M | 34.08% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $663.49K | 5.58% | 2026-06-30 |
| 4 | Wolverine Trading, LLC Custodian | $527.13K | 4.44% | 2025-09-30 |
| 5 | Walleye Capital LLC | $401.18K | 3.38% | 2026-06-30 |
| 6 | Citadel Advisors LLC Custodian | $262.31K | 2.21% | 2026-06-30 |
SOLV Insider Trading (Form 4)
Latest: 2026-09-03Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Bryan C Hanson | Chief Executive Officer | Mixed | +40,793 | $90.95 | -$2.41M | EDGAR |
| 2026-08-18 | Neil Craig Zieselman | SVP, Controller & CAO | Grant (A) | +6,911 RSU | — | EDGAR | |
| 2026-05-18 | Darryl L. Wilson | Director | Grant (A) | +3,300 RSU | — | EDGAR | |
| 2026-05-18 | Amy McBride Wendell | Director | Grant (A) | +3,300 RSU | — | EDGAR | |
| 2026-05-18 | John H Weiland | Director | Grant (A) | +3,300 RSU | — | EDGAR | |
| 2026-05-18 | Elizabeth Mily | Director | Grant (A) | +3,300 RSU | — | EDGAR | |
| 2026-05-18 | Karen J May | Director | Grant (A) | +3,300 RSU | — | EDGAR | |
| 2026-05-18 | Bernard A Harris Jr | Director | Grant (A) | +3,300 RSU | — | EDGAR | |
| 2026-05-18 | Glenn A Eisenberg | Director | Grant (A) | +3,300 RSU | — | EDGAR | |
| 2026-05-18 | Shirley Ann Edwards | Director | Grant (A) | +3,300 RSU | — | EDGAR | |
| 2026-05-18 | Susan D. DeVore | Director | Grant (A) | +3,300 RSU | — | EDGAR | |
| 2026-05-18 | Carrie Smith Cox | Director | Grant (A) | +4,848 RSU | — | EDGAR | |
| 2026-05-18 | Carlos Alban | Director | Grant (A) | +3,300 RSU | — | EDGAR | |
| 2026-05-15 | Amy Landucci | Chief Information Officer | Mixed | +2,405 | $74.41 | -$150.1K | EDGAR |
| 2026-05-15 | Bryan C Hanson | Chief Executive Officer | Mixed | +20,812 | $74.41 | -$1.00M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
SOLV Insider Holdings
21 insiders · @ $86.67
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | 3M CO | 10%+ Owner | 25,569,190 | $2.22B | -$646.36M | 3 | 2025-08-18 |
| 2 | Bryan C Hanson | Chief Executive Officer | 185,515 | $16.08M | $0 | 8 | 2026-09-03 |
| 3 | Wayde D. McMillan | Chief Financial Officer | 53,041 | $4.60M | $0 | 7 | 2026-05-15 |
| 4 | Amy Landucci | Chief Information Officer | 41,905 | $3.63M | $0 | 7 | 2026-05-15 |
| 5 | Paul S Harrington | Chief Supply Chain Officer | 22,130 | $1.92M | $0 | 7 | 2026-05-15 |
| 6 | Carrie Smith Cox | Director | 16,400 | $1.42M | $0 | 6 | 2026-05-18 |
| 7 | Marcela A. Kirberger | Chief Legal Affairs Officer | 15,492 | $1.34M | $0 | 7 | 2026-05-15 |
| 8 | Tammy L Gomez | Chief Human Resources Officer | 15,030 | $1.30M | $0 | 7 | 2026-05-15 |
| 9 | Amy McBride Wendell | Director | 10,422 | $903.3K | $100.3K | 7 | 2026-05-18 |
| 10 | Elizabeth Mily | Director | 9,009 | $780.8K | $0 | 6 | 2026-05-18 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
SOLV Board & Officers
As of SEC filings through Sep 3, 2026Directors 12
- Amy McBride Wendell · since Apr 1, 2024
- Bernard A Harris Jr · since Apr 1, 2024
- Bryan C Hanson · since Apr 1, 2024
- Carlos Alban · since Apr 1, 2024
- Carrie Smith Cox · since Apr 1, 2024
- Darryl L. Wilson · since Apr 1, 2024
- Elizabeth Mily · since Apr 1, 2024
- Glenn A Eisenberg · since Apr 1, 2024
- John H Weiland · since Apr 1, 2024
- Karen J May · since Apr 1, 2024
- Susan D. DeVore · since Apr 1, 2024
- Shirley Ann Edwards · since Apr 12, 2024
Officers 8
- Bryan C Hanson · Chief Executive Officer · since Apr 1, 2024
- Wayde D. McMillan · Chief Financial Officer · since Apr 1, 2024
- Amy Landucci · Chief Information Officer · since Apr 1, 2024
- Paul S Harrington · Chief Supply Chain Officer · since Apr 1, 2024
- Tammy L Gomez · Chief Human Resources Officer · since Apr 1, 2024
- Marcela A. Kirberger · Chief Legal Affairs Officer · listed since Dec 2024
- Heather Knight · Chief Commercial Officer · since Nov 10, 2025
- Neil Craig Zieselman · SVP, Controller & CAO · since Aug 10, 2026
10% owners 1
- 3M CO · since Mar 13, 2024
Changes in the last 10 years (35)
| Aug 10, 2026 | Neil Craig Zieselman became SVP, Controller & CAO |
| Mar 20, 2026 | The company announced the departure of Mary T Wilcox as Chief Accounting Officer in an SEC filing |
| Nov 10, 2025 | Heather Knight became Chief Commercial Officer |
| Oct 17, 2025 | The company announced the departure of Chris Barry as Executive Vice President in an SEC filing |
| Dec 3, 2024 | Solventum Corp first on file as Chief Legal Affairs Officer |
| Dec 3, 2024 | Marcela A. Kirberger listed as Chief Legal Affairs Officer (previously Chief Legal Officer) in SEC filings |
| Apr 12, 2024 | Shirley Ann Edwards became a director |
| Apr 1, 2024 | Wayde D. McMillan became Chief Financial Officer |
| Apr 1, 2024 | Tammy L Gomez became Chief Human Resources Officer |
| Apr 1, 2024 | Susan D. DeVore became a director |
| Apr 1, 2024 | Paul S Harrington became Chief Supply Chain Officer |
| Apr 1, 2024 | Mary T Wilcox became Chief Accounting Officer |
| Apr 1, 2024 | Marcela A. Kirberger became Chief Legal Officer |
| Apr 1, 2024 | Karen J May became a director |
| Apr 1, 2024 | John H Weiland became a director |
| Apr 1, 2024 | Glenn A Eisenberg became a director |
| Apr 1, 2024 | Elizabeth Mily became a director |
| Apr 1, 2024 | Darryl L. Wilson became a director |
| Apr 1, 2024 | Chris Barry became Executive Vice President |
| Apr 1, 2024 | Carrie Smith Cox became a director |
| Apr 1, 2024 | Carlos Alban became a director |
| Apr 1, 2024 | Bryan C Hanson became a director |
| Apr 1, 2024 | Bryan C Hanson became Chief Executive Officer |
| Apr 1, 2024 | Bernard A Harris Jr became a director |
| Apr 1, 2024 | Amy McBride Wendell became a director |
| Apr 1, 2024 | Amy Landucci became Chief Information Officer |
| Mar 13, 2024 | Theresa E Reinseth became a director |
| Mar 13, 2024 | Teresa K Crockett became a director |
| Mar 13, 2024 | Teresa K Crockett became President |
| Mar 13, 2024 | Rodolfo Espinosa-Casaubon became a director |
| Mar 13, 2024 | Rodolfo Espinosa-Casaubon became Treasurer |
| Mar 13, 2024 | Michael J. Ottesen became a director |
| Mar 13, 2024 | Michael J. Ottesen became Vice President |
| Mar 13, 2024 | Justin McGough became a director |
| Mar 13, 2024 | 3M CO became a 10% owner |
Not reported recently (6)
- Solventum Corp · Last reported as Chief Legal Affairs Officer in an SEC filing dated Dec 10, 2024
- Michael J. Ottesen · Last reported as a director in an SEC filing dated Mar 13, 2024
- Theresa E Reinseth · Last reported as a director in an SEC filing dated Mar 13, 2024
- Justin McGough · Last reported as a director in an SEC filing dated Mar 13, 2024
- Rodolfo Espinosa-Casaubon · Last reported as a director in an SEC filing dated Mar 13, 2024
- Teresa K Crockett · Last reported as a director in an SEC filing dated Mar 13, 2024
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
Recent SEC Filings
Latest: 2026-06-05
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Accession | Link |
|---|---|---|
| 2026-06-05 | 0001964738-26-000036 | EDGAR |
| 2026-05-27 | 0001964738-26-000031 | EDGAR |
| 2026-05-20 | 0001964738-26-000027 | EDGAR |
| 2026-05-05 | 0001964738-26-000022 | EDGAR |
| 2026-03-24 | 0001964738-26-000013 | EDGAR |
| 2026-02-26 | 0001964738-26-000005 | EDGAR |
| 2025-12-16 | 0001964738-25-000094 | EDGAR |
| 2025-11-06 | 0001964738-25-000089 | EDGAR |
| 2025-10-21 | 0001628280-25-045731 | EDGAR |
| 2025-09-08 | 0001964738-25-000084 | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
ETF Holders
201 ETFs hold SOLV
25 shown · $2.30B total exposure · 0.03% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.02% | $404.4M | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.02% | $334.8M | — | 2026-09-30 |
| 3 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.16% | $287.1M | — | 2026-09-30 |
| 4 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.19% | $188.3M | — | 2026-10-20 |
| 5 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.29% | $186.9M | — | 2026-09-30 |
| 6 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.02% | $166.2M | $890.4B | 2026-10-20 |
| 7 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.02% | $153.8M | $818.4B | 2026-10-20 |
| 8 | XLV State Street® Health Care Select Sector SPDR® ETF | SPDR (State Street) | 0.19% | $91.1M | $47.5B | 2026-10-20 |
| 9 | DFAT Dimensional US Targeted Value ETF | Dimensional | 0.28% | $85.7M | — | 2026-10-20 |
| 10 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.09% | $53.5M | $57.3B | 2026-10-20 |
| 11 | VHT Vanguard Health Care ETF | Vanguard | 0.18% | $39.7M | — | 2026-09-30 |
| 12 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.02% | $34.4M | $183.5B | 2026-10-20 |
| 13 | SCHM Schwab U.S. Mid-Cap ETF | Nport | 0.20% | $29.9M | — | 2026-05-31 |
| 14 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.03% | $28.4M | $84.5B | 2026-10-20 |
| 15 | DUSA Davis Select U.S. Equity ETF | Nport | 2.11% | $26.8M | — | 2026-07-31 |
| 16 | FXH First Trust Health Care AlphaDEX® Fund | First Trust | 2.25% | $25.7M | $1.1B | 2026-10-20 |
| 17 | SPHQ Invesco S&P 500 Quality ETF | Invesco | 0.13% | $25.1M | — | 2026-10-20 |
| 18 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.03% | $24.7M | — | 2026-10-20 |
| 19 | IVE iShares S&P 500 Value ETF | iShares (BlackRock) | 0.04% | $21.0M | $50.4B | 2026-10-20 |
| 20 | IWS iShares Russell Mid-Cap Value ETF | iShares (BlackRock) | 0.12% | $19.4M | $15.6B | 2026-10-20 |
| 21 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.02% | $16.4M | $97.4B | 2026-10-20 |
| 22 | SPYV State Street® SPDR® Portfolio S&P 500® Value ETF | SPDR (State Street) | 0.04% | $15.9M | $38.3B | 2026-10-20 |
| 23 | RSPH Invesco S&P 500 Equal Weight Health Care ETF | Invesco | 1.47% | $14.1M | — | 2026-10-20 |
| 24 | FNDX Schwab Fundamental U.S. Large Company ETF | Nport | 0.05% | $12.7M | — | 2026-05-31 |
| 25 | CSD Invesco S&P Spin-Off ETF | Nport | 5.31% | $12.0M | — | 2026-07-31 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
10.61
TTM Diluted EPS
$8.17
TTM Revenue
$8.31B
TTM Net Income
$1.43B
TTM Op. Cash Flow
$209.00M
Quarterly figures (9 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $2.21B | $92.00M | $0.53 | $227.00M |
| Q1 '26 | 2026-03-31 | $2.01B | $13.00M | $0.07 | $-189.00M |
| Q4 '25 | 2025-12-31 | $2.00B | $63.00M | $0.35 | $95.00M |
| Q3 '25 | 2025-09-30 | $2.10B | $1.27B | $7.22 | $76.00M |
| Q2 '25 | 2025-06-30 | $2.16B | $90.00M | $0.51 | $169.00M |
| Q1 '25 | 2025-03-31 | $2.07B | $137.00M | $0.78 | $29.00M |
| Q4 '24 | 2024-12-31 | $2.08B | $31.00M | $0.18 | $219.00M |
| Q3 '24 | 2024-09-30 | $2.08B | $122.00M | $0.70 | $169.00M |
| Q2 '24 | 2024-06-30 | $2.08B | $89.00M | $0.51 | $355.00M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-05
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
10.61
P/B
3.16
P/S
1.82
EV/EBITDA
18.91
EV/Sales
2.35
ROE
29.9%
ROA
10.1%
Div Yield
0.00%
FCF Yield
1.38%
Debt/Equity
1.00
Current Ratio
—
Market Cap
$15.16B
as of 2026-10-21
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
4.89M
SI % of Float
3.38%
Days to Cover
5.43
Short Vol Ratio
63.0%
Free Float
144.86M
Float %
85.1%
Short interest 2026-09-30 • Short volume 2026-10-21 • Float 2026-08-07